Travis Kotter, DPM
Foot & Ankle Surgery · Colorado Springs, CONPI 1457746844
Payments from drug & device makers
Across 40 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$82
- Stryker$65
- Hologic Sales And Service, LLC$61
- AstraZeneca$51
- Biohaven Pharmaceuticals, Inc.$50
- Biohaven Pharmaceutical Holding Company Ltd.$49
- plus $408 from 18 others
What the payments were for
- Food & beverage$73596%
- Education$324%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $82 |
| Stryker | 3 | $65 |
| Hologic Sales And Service, LLC | 3 | $61 |
| AstraZeneca(2 entities) | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 2 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $49 |
| Johnson & Johnson | 3 | $45 |
| Amgen(2 entities) | 2 | $34 |
| Active Medical, LLC | 1 | $32 |
| Scilex Pharmaceuticals Inc. | 2 | $29 |
| Smith+Nephew | 2 | $27 |
| Astellas Pharma US Inc | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $25 |
| Mimedx Group, Inc. | 1 | $25 |
| Nevro Corp. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Medtronic | 1 | $17 |
| Paragon 28, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Merck | 1 | $11 |
How this compares
$767 in reported general payments places this provider in the 20th percentile of 181 foot & ankle surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 85 | $611 |
| Doxycycline Hyclate | 37 | $266 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $246 |
| Pregabalin | 16 | $101 |
| Allopurinol | 24 | $97 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Colorado Springs
- Brad DresherColorado Springs$1.3M
- William MontrossColorado Springs$239K
- John ShankColorado Springs$106K
- Matthew HinderlandColorado Springs$47K
- Jordan CameronColorado Springs$17K
- Michael SimpsonColorado Springs$13K
- Belinda LiauColorado Springs$7K
- Michael HoughtonFort Collins$2M
- Joshua MetzlEnglewood$1.9M
- Thomas ClantonVail$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.